https://www.marketscreener.com/quote/stock/BOUNDLESS-BIO-INC-167693659/news/Boundless-Bio-Announces-First-Patient-Dosed-in-First-in-Human-Phase-1-2-Clinical-Trial-of-BBI-825-in-46414025/?utm_source=telegram&utm_medium=social&utm_campaign=share